These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7802985)

  • 1. Survival in HIV infection: do sex and category of transmission matter? Swiss HIV Cohort Study.
    von Overbeck J; Egger M; Smith GD; Schoep M; Ledergerber B; Furrer H; Malinverni R
    AIDS; 1994 Sep; 8(9):1307-13. PubMed ID: 7802985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology.
    Pehrson P; Lindbäck S; Lidman C; Gaines H; Giesecke J
    AIDS; 1997 Jul; 11(8):1007-12. PubMed ID: 9223735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men.
    Spijkerman IJ; Koot M; Prins M; Keet IP; van den Hoek AJ; Miedema F; Coutinho RA
    AIDS; 1995 Sep; 9(9):1085-92. PubMed ID: 8527083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.
    Prins M; Veugelers PJ
    AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in laboratory values in HIV infection by sex, race, and risk group.
    Gorter RW; Vranizan KM; Osmond DH; Moss AR
    AIDS; 1992 Nov; 6(11):1341-7. PubMed ID: 1361747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
    Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
    Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study.
    Cozzi Lepri A; Pezzotti P; Dorrucci M; Phillips AN; Rezza G
    BMJ; 1994 Dec; 309(6968):1537-42. PubMed ID: 7819892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of AIDS in the Oslo HIV-cohort study. A comparison between homosexual men, intravenous addicts and heterosexual persons].
    Eskild A; Heger B; Bruun JN; Frøland SS; Iversen B; Løvik M; Samdal HH; Magnus P; Bakketeig LS
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2831-4. PubMed ID: 7998028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall and cause-specific mortality in a cohort of homo-/bisexual men, injecting drug users, and female partners of HIV-infected men. Pulmonary Complications of Human Immunodeficiency Virus Infection Study Group.
    Poole WK; Fulkerson W; Lou Y; Kvale P; Hopewell PC; Hirschtick R; Glassroth J; Rosen M; Mangura B; Wallace J; Markowitz N
    AIDS; 1996 Sep; 10(11):1257-64. PubMed ID: 8883588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics.
    Ledergerber B; von Overbeck J; Egger M; Lüthy R
    Soz Praventivmed; 1994; 39(6):387-94. PubMed ID: 7817627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men.
    Prins M; Sabin CA; Lee CA; Devereux H; Coutinho RA
    AIDS; 2000 Aug; 14(12):1829-37. PubMed ID: 10985321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual behaviour of heterosexual individuals with HIV infection naive for antiretroviral therapy in Italy.
    Girardi E; Aloisi MS; Serraino D; Ferrara M; Lauria FN; Carballo M; d'Arminio Monforte A; Rezza G; Moroni M; Carosi G; Alessandrini A; Giacobbi D; Cremonini L; Ranieri S; Montroni M; Ippolito G;
    Sex Transm Infect; 2001 Apr; 77(2):130-4. PubMed ID: 11287693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early participation in an HIV cohort study slows disease progression and improves survival. The Swiss HIV Cohort Study.
    Battegay M; Wirz M; Steuerwald MH; Egger M
    J Intern Med; 1998 Dec; 244(6):479-87. PubMed ID: 9893101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men.
    Lyles CM; Graham NM; Astemborski J; Vlahov D; Margolick JB; Saah AJ; Farzadegan H
    Eur J Epidemiol; 1999 Feb; 15(2):99-108. PubMed ID: 10204638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
    Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
    AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
    García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
    J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.